We use cookies to understand how our site is used so we can improve it. Necessary cookies are always on. You can accept all, reject all, or choose what to allow. Learn more
Beauty & CosmeticsFirst to the category, late to the wave.
Beauty & Cosmetics
First to the category, late to the wave.
In 2019 Korea exported US$6.6bn of cosmetics; in 2025, a record US$11.4bn — second in the world only to France. Behind that climb sits a single repeatable playbook — one clean 'hero' product, sold online, exported brand-first — that a generation of tiny Korean indies used to build global businesses with no factory of their own. Manyo Factory helped write that playbook, then watched later brands run it to two-to-three times its scale. Read as a market rather than a stock, the gap between them is the clearest lesson K-beauty offers about what actually compounds — a repeatable engine for making heroes — and what is only ever one hit.
Clean, vegan, ingredient-led skincare — the category Manyo Factory helped open in Korea in the 2010s. A decade later the same playbook built bigger brands, and the pioneer is now being professionalised by a private-equity owner.
In 2019, South Korea exported about US$6.6 billion of cosmetics. In 2025 it exported a record US$11.4 billion — enough to make Korea the world's second-largest beauty exporter behind only France, and to pass the United States as a source of the products the rest of the world puts on its face. That climb is the backdrop to everything here. But the more useful story is not the total. It is the playbook underneath it: a single, repeatable formula that a generation of tiny Korean brands used to build export businesses out of almost nothing — and what happens to the ones that ran it first.
The formula is easy to state and hard to own. Make one 'hero' product in a clean, vegan, ingredient-led register; sell it direct and online; and export it brand-first, before you have a distributor or a shelf. Run well, it turns a contract-manufactured SKU into a global franchise in eighteen months. This is a study of that market through the brand that helped invent the formula — Manyo Factory — and of why being first to a market is not the same as owning it.
Korea cosmetics exports, 2025 — a record, and a #2 global ranking
≈US$11.4bn
Up from ~US$6.6bn in 2019 (~9–10% a year), behind only France and ahead of the US. Skincare — the category this playbook lives in — is roughly 75% of the mix. Source: MFDS / Korea Customs Service.
The market: one playbook, a thousand brands
What makes K-beauty a genuine market phenomenon rather than a run of lucky brands is that the playbook is reproducible — and it is reproducible because almost no one in it owns a factory. The entire export wave rides on a shared contract-manufacturing backbone: a handful of Korean ODM houses, chiefly Cosmax, Korea Kolmar and Cosmecca, that will formulate, fill and finish a product for anyone with a brand and a marketing budget. The founder brings a name, a story and a social-video account; the ODM brings the chemistry. That is why a clean-beauty brand can go from idea to Amazon bestseller without ever pouring concrete for a plant — and why a new cohort of entrants arrives every season.
It also settles where the money is, and isn't. Because the formulation is shared and the manufacturing is rented, the moat is almost never the product chemistry. It is the brand and the channel, and occasionally a piece of proprietary device or applicator technology bolted on top. Research and development for a typical indie runs a fraction of one percent of sales. The barrier to entry is low by design — the market's great strength on the way up and its central problem at maturity, because the same openness that let the pioneers in lets their imitators in just as quickly.
The unit of competition in this market is a single hero SKU. Manyo's Pure Cleansing Oil — Olive Young's #1 cleanser for five straight years — is the textbook example: one contract-manufactured product turned into a franchise through name and channel, not a factory.
What is driving it, and where it goes by 2030
Three forces are pushing the wave, and all three have years left to run. The first is reach: Korean beauty now travels on the same rails as Korean music and film, discovered on social video and bought on global marketplaces — Amazon, TikTok Shop, Olive Young Global — that barely existed for a small brand a decade ago. The second is breadth: K-beauty has grown from a China-dependent trade into a genuinely global one, selling into more than 200 countries and into new buyers, including a fast-growing men's segment. The third is the category itself: skincare, about three-quarters of Korea's beauty exports, is a habit rather than a fashion — a daily, repeat-purchase routine that compounds.
Sized forward, the independent forecasts converge on continued high-single-digit growth: global K-beauty is projected to roughly double, to around US$187 billion by 2030, a compound rate near 9%. Treat that as a direction of travel rather than a precise figure — the published estimates vary with how 'K-beauty' is drawn — but the shape is not in dispute. The category keeps compounding, and it does so while its centre of gravity moves underneath it.
Global K-beauty market — 2030 forecast (a direction, not a point estimate)
≈US$187bn
Roughly double today's market, at a high-single-digit CAGR. Skincare is the bulk; the US and Japan are the growth engines. The figure spans a wide band across sources — the trajectory is the reliable part, not the decimal.
The rotation: out of China, into the US and Japan
The single most important structural fact in this market over the past five years is a change of destination. For years China was K-beauty's centre — and then it wasn't. Korean cosmetics exports to China fell from a peak near US$4.8 billion to about US$2.0 billion in 2025, hit by a nationalist turn toward home-grown 'C-beauty' and the long tail of diplomatic friction. Over the same span the United States went the other way — from roughly US$0.8 billion in 2021 to about US$2.2 billion in 2025 — overtaking China as the number-one destination for the first time. Japan now sits third and rising. The market did not simply grow; it relocated.
Korea's cosmetics exports dipped when China fell away in 2022, then powered to a record as the US took over — the market relocated and grew at the same time.
This rotation is the tailwind for any brand pointed at America and Japan — exactly where the indie cohort, Manyo included, is now aiming. But it arrives with a headwind that will reshape who wins. In August 2025 the United States imposed a roughly 15% tariff on Korean goods and ended the 'de-minimis' exemption that had let small parcels enter duty-free — the very mechanism the cross-border indie model was built on. The immediate effect showed up in the trade data, with US-bound shipments dropping sharply month-on-month; the lasting effect is structural. It raises the cost of shipping a brand into America from Seoul and pushes the larger players to manufacture locally. A border rule has quietly become a competitive sorting mechanism.
Discovery is half the market. Olive Young at home — and Olive Young Global, Amazon and TikTok Shop abroad — are the shelves where heroes are made. Winning the discovery channel is now as decisive as the product in the bottle.
How the wave sorted itself: four ways to win
By 2025 the indie cohort had split into clearly different business models, and the distance between them is the most instructive thing in the market. Four archetypes pulled ahead — and a brand built on a single undifferentiated hero sits awkwardly outside all of them.
The device-and-consumable ecosystem. APR pairs an at-home beauty device (AGE-R) with its Medicube skincare line — a razor-and-blades loop where the gadget pulls through repeat consumable sales. It is the fastest-scaling model in the cohort.
The explosive single hero, at scale. d'Alba built a half-billion-dollar business on one white-truffle spray serum pushed through aggressive global online — proof a single SKU can scale, if a brand drives it hard enough, fast enough, everywhere at once.
The picks-and-shovels platform. Silicon2 bets on no single brand; it distributes the wave's products into export markets and captures value regardless of which brand is hot this season — the infrastructure layer of K-beauty.
The proprietary-format brand. VT turned its patented Reedle Shot micro-spicule format into a defensible hero — a product a rival cannot simply reorder off the same ODM shelf.
Company (KOSDAQ/KOSPI)
FY23 rev
FY25 rev
CAGR
FY25 margin
Model
APR (278470)
₩523.8bn
₩1,527.3bn
+70.8%
23.9%
Device + consumable
Silicon2 (257720)
₩342.9bn
₩1,116.3bn
+80.4%
18.4%
Export platform
d'Alba (483650)
₩200.8bn
₩519.7bn
+60.9%
19.5%
Single hero at scale
VT (018290)
₩295.5bn
₩437.2bn
Read down the table and the market's verdict is plain. What compounds in K-beauty is not a hit; it is a repeatable engine for making hits — a device that pulls consumables, a platform that taxes the whole wave, or a proprietary format a rival cannot copy by reordering. A single hero, however good, is a position the market can grow past. That is the structural box Manyo sits in: it owns one of the most durable single heroes in Korea, and little else of scale.
The case in point: the pioneer's trap
Manyo Factory is worth studying precisely because it ran the playbook first. Before 'clean beauty' was a phrase in any Western department store, Manyo was already selling a clean, vegan, ingredient-led hero — the Pure Cleansing Oil, a plant-oil makeup remover that became a national staple. It has sold on the order of 22 million bottles and has been Olive Young's number-one cleanser for five years running. Cleansing is the most defensible corner of the routine to own: a daily, repeat-purchase habit, in a lane less crowded than the toner, serum or cushion lanes the rest of the cohort fights over. Roughly 58% of Manyo's revenue still comes from that single category.
And there the trap closes. The brands that ran the same playbook later compounded two-to-three times while Manyo went flat — because they built a second engine and Manyo did not. The Korean trade press states the problem bluntly: the company 'has not produced a big hit since the cleansing oil.' One signal cuts the other way, and it is a market signal rather than a financial one: Korean customs reportedly seized 952 counterfeit Manyo products in a recent year — more than the number found for Sulwhasoo — making it among the most-counterfeited K-beauty skincare brands on record. Counterfeiters copy what sells. The category pull is genuine; the open question is whether a second product can be built on top of it.
That is the question the brand's new owner is now testing. A private-equity firm took control in 2025 and is professionalising Manyo and re-pointing it at the rotation described above — trimming low-quality China volume and building toward the US and Japan, where the cleansing hero has begun to land at Costco and, in 2026, Ulta. The reset is sensible, and a net-cash, debt-free balance sheet can fund it. But cost discipline and a cleaner channel mix cannot manufacture a second hero; only product can. This one will be decided in the market, not on a spreadsheet.
The unsolved problem is not the hero oil — it is the second act: a US franchise deep enough to move the total, built against incumbents who already have one, and now against a 15% tariff that did not exist a year ago.
“In a market with no manufacturing moat, being first to a category buys credibility, not ownership. What compounds is a repeatable engine for making heroes — a device, a platform, a proprietary format. A single great product is a beginning the market can grow past.”
— Nathan Research Group, Consumer Beauty Series N°01
What wins from here
Project the market forward and two things happen at once. The category keeps compounding toward roughly US$187 billion by 2030 — and it consolidates, because the US tariff and the end of de-minimis raise the cost of the pure cross-border, ship-it-from-Seoul model that defined the first wave. Advantage shifts toward brands with a repeatable engine, the scale to localise production, or a place in the infrastructure layer, and away from sub-scale single-SKU brands selling across a newly taxed border. Maturity rewards engines and punishes one-hit names.
For a pioneer like Manyo, that sorts into three market outcomes — defined by what gets built and where the brand lands in the cohort, not by any target valuation.
Path
What would have to be true in the market
Where the brand lands
The second act works
A second hero scales and the US/Japan build becomes an owned demand leg, not a rival's shelf.
Joins the export-native winners.
A profitable specialist
The cleansing franchise grows modestly abroad, but no breakout second product arrives.
A durable mid-sized brand on its category.
Consolidation candidate
No second hero; tariff pressure and cost-cutting starve demand generation.
Absorbed into a larger K-beauty platform.
Illustrative market-and-execution scenarios — analytical constructs to frame the question, not forecasts of record. Each is defined by a market and capability outcome, anchored to the cohort's demonstrated growth paths and the 2025–2030 trade environment.
The lesson generalises beyond one brand, and beyond beauty. In any market where manufacturing is outsourced and the formula is shared — consumer apps, supplements, fast fashion, much of consumer electronics — category creation is not category ownership, and the durable economics belong to whoever builds a repeatable engine or owns the distribution, not to whoever shipped the first good product. K-beauty is simply the clearest current laboratory for that rule, growing fast enough that the difference between an engine and a hit shows up in a single year's numbers. Nathan Research Group has specialised in the Korean economy since 2013; the most revealing question about a fast-growing brand is rarely 'how good is the hero?' — it is 'what builds the next one?' Our full brief on the K-beauty export market — the sizing, the channel economics, the competitive map and the trade-policy outlook — is available to download with this article.
Working With Nathan Research Group
Partner With Nathan Research Group
Public filings establish the shape of Manyo Factory — the rebrand, the US headline, the sponsor. What they cannot show — how durable the hero franchise really is, the real channel economics behind the US and Japan build, how the cost reset is landing inside the business — lives with the people who built, marketed, sold, distributed and competed with these brands. Reaching them, compliantly, is what we do.
Korea’s first dedicated expert network — Seoul, since 2013
Who we put in the room
Former executives & founders
Manyo, L&P/Mediheal and KL&Partners, plus peer brand houses — d'Alba, APR, Anua and the Goodai brands.
Brand, performance-marketing & e-commerce
Amazon US and TikTok Shop growth leads, Olive Young Global, and DTC and Japan specialists.
ODM & supply-chain specialists
Cosmax, Kolmar and Cosmecca formulators and capacity planners on cost, lead-time and IP.
Channel & retail buyers
Olive Young, Ulta, Costco and Target (US), at@cosme and Japanese distributors.
Total Korea cosmetics exports (bars) and the US share of them (line). The 2022 dip is China falling away; the 2024–25 record is the US and Japan more than replacing it, with the US share climbing to ~19% (≈US$2.2bn of US$11.4bn). Figures approximate, rounded. Source: MFDS / Korea Customs Service.
+21.6%
19.0%
Proprietary format
Clio (237880)
₩330.6bn
₩328.9bn
−0.3%
5.0%
Legacy multi-line
Manyo Factory (439090)
₩105.0bn
₩113.0bn
+3.7%
9.3%
Single hero, no device
Listed-peer audited financials (consolidated, OpenDART, FY2023–25); CAGR and operating margin computed from those figures. The winners share a repeatable engine — a device loop, a platform, or a proprietary format. The brands anchored to one undifferentiated hero (Clio, Manyo) are the ones that stalled while the market doubled around them.
Efficacy, repeat-purchase and brand-equity reads on the cleansing and Active Beauty lines.
Regulatory & trade specialists
MFDS, FDA and PMDA cosmetics registration, and US tariff and trade exposure.
How an engagement works
1Scope
We turn your thesis into a precise expert profile and question set, mapped to the decisions you need to close.
2Source & vet
We screen and compliance-clear each expert — relevance, recency, and the absence of conflicts — before any call.
3Convene & synthesize
We arrange interviews on your timeline and, where useful, deliver written synthesis tied back to your questions.
If your team is evaluating Manyo Factory, the Korean indie and clean-beauty sector, or the broader K-beauty export supply chain, tell us the decision you’re trying to make.
A direct reply from a partner, not an intake form.
Based solely on public sources. Nathan Research Group does not request or facilitate material non-public information, and runs every engagement through a documented compliance protocol.
